Elizabeth M. Swisher

Author

Also Known As

Alexander Dobrovic, Australian Ovarian Cancer Study, Australian Ovarian Cancer Study (AOCS), Bruce Robinson, Carl Simon Shelley, Cassaundra Shipman, David D. Bowtell, E M Swisher, E SWISHER, E Swisher

732

Publications

65.5K

Citations

103

H-Index

140

Concepts

All Affiliations

University of Washington University of Washington Medical Center The University of Texas MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center Fred Hutch Cancer Center

About

Elizabeth M. Swisher is an author at University of Washington specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	95	15K
2	Health Sciences	10	11	1.8K
3	Arts	1	1	10
4	Engineering	1	1	895
5	Humanities	1	1	10

Elizabeth M. Swisher

184

Publications

27.7K

Citations

H-Index

Page 1

	Year	Citations
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Robert L. Coleman, Amit M. Oza, Domenica Lorusso, The Lancet Rucaparib Maintenance TreatmentMedicineRecurrent Ovarian CarcinomaGynecologyCancer Treatment	2017	1.7K
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial Elizabeth M. Swisher, Kevin Lin, Amit M. Oza, The Lancet Oncology MedicinePharmacologyPathologyCancer TreatmentOncology	2016	1.2K
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers Wataru Sakai, Elizabeth M. Swisher, Beth Y. Karlan, Nature Cisplatin ResistanceSomatic VariantTumor HeterogeneitySecondary MutationsMedicine	2008	1.1K
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas Kathryn P. Pennington, Tom Walsh, Maria I. Harrell, Clinical Cancer Research	2013	1K
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing Tom Walsh, Silvia Casadei, Ming K. Lee, Proceedings of the National Academy of Sciences Somatic VariantPoint MutationsTumor HeterogeneityVariant InterpretationGenetics	2011	929
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer Robert L. Coleman, Gini F. Fleming, Mark F. Brady, New England Journal of Medicine	2019	886
Inherited Mutations in Women With Ovarian Carcinoma Barbara M. Norquist, Maria I. Harrell, Mark F. Brady, JAMA Oncology	2015	748
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer Tom Walsh, Silvia Casadei, Kathryn Hale Coats, JAMA	2006	662
Genetic/Familial High-Risk Assessment: Breast and Ovarian Mary B. Daly, Jennifer E. Axilbund, Saundra S. Buys, Journal of the National Comprehensive Cancer Network	2010	649

Page 1